Skip to content
Disclosery

EXANE DERIVATIVES: CMCSA position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of EXANE DERIVATIVES on CMCSA, newest first. How the timeline and the estimate are built.

EXANE DERIVATIVES held 954 CMCSA shares at 2022-06-30 per its 13F-HR filed 2022-07-12.

the latest 13F is the newest step

  1. period ended2022-06-30
    13F 954 shares
    Change vs previous 13F +54 shares

    0.02% of the 13F portfolio, value $37,431.

    13F-HR 0001623883-22-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2022-03-31
    13F 900 shares
    Change vs previous 13F +765 shares

    0.01% of the 13F portfolio, value $42,138.

    13F-HR 0001623883-22-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2021-12-31
    13F 135 shares
    Change vs previous 13F -710 shares

    <0.01% of the 13F portfolio, value $6,795.

    13F-HR 0001623883-22-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2021-09-30
    13F 845 shares
    Change vs previous 13F -5,355 shares

    0.01% of the 13F portfolio, value $47,262.

    13F-HR 0001623883-21-000008 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2021-06-30
    13F 6,200 shares
    Change vs previous 13F +29 shares

    0.08% of the 13F portfolio, value $358,491.

    13F-HR 0001623883-21-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2021-03-31
    13F 6,171 shares
    Change vs previous 13F +6,152 shares

    0.1% of the 13F portfolio, value $333,925.

    13F-HR 0001623883-21-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2020-12-31
    13F 19 shares
    Change vs previous 13F 0 shares

    <0.01% of the 13F portfolio, value $996.

    13F-HR 0001623883-21-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2020-09-30
    13F/A 19 shares
    Change vs previous 13F not available

    <0.01% of the 13F portfolio, value $879.

    13F-HR/A 0001623883-20-000010 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).